0.3000
+0.0200
+(7.14%)
At close: 3:37:23 PM GMT+10
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Cash Flows from Used in Operating Activities Direct
-155.8640
-155.8640
-660.4640
-3,591.2720
2,418.6340
Investing Cash Flow
-416.1290
-416.1290
-48.1320
-8.4660
-7.7840
Financing Cash Flow
3,134.1490
3,134.1490
916.2660
-97.8350
400
End Cash Position
2,864.9480
2,864.9480
302.7920
95.1220
3,792.6950
Interest Paid Supplemental Data
14.9860
14.9860
98.2650
41.4070
231.6710
Capital Expenditure
-52.3810
--
--
-8.4660
-7.7840
Issuance of Capital Stock
3,481.1640
3,481.1640
--
--
1,500
Issuance of Debt
3,805.9300
--
1,347.0150
1,000
--
Repayment of Debt
-347.0150
-347.0150
-400
-1,262.7000
-1,100
Free Cash Flow
-155.8640
-155.8640
-660.4640
-3,599.7380
2,410.8500
6/30/2021 - 7/17/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
VBS.AX Vectus Biosystems Limited
0.0800
0.00%
IXC.AX Invex Therapeutics Ltd
0.0700
0.00%
NSB.AX NeuroScientific Biopharmaceuticals Limited
0.0350
0.00%
BTC.AX BTC Health Limited
0.0460
-8.00%
RNV.AX RENERVE FPO [RNV]
0.1100
+4.76%
1AI.AX Algorae Pharmaceuticals Limited
0.0060
+20.00%
ANR.AX Anatara Lifesciences Ltd
0.0060
0.00%
TRP.AX Tissue Repair Ltd
0.2400
0.00%
ATX.AX Amplia Therapeutics Limited
0.0520
-1.89%
BGT.AX Bio-Gene Technology Limited
0.0310
0.00%